Jerry Hall

发表

Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study

J. Graham, J. Boscarino, E. Wright, 2022, Rheumatology and Therapy.

Does Pain Cause the Perception of Fatigue in Patients with Chronic Pain? Findings from Studies for Management of Diabetic Peripheral Neuropathic Pain with Duloxetine

D. Fishbain, R. Risser, Jerry Hall, 2009, Pain practice : the official journal of World Institute of Pain.

Electronic health databases for epidemiological research on joint replacements: considerations when making cross-national comparisons.

M. Bonafede, D. Oleske, S. Jick, 2014, Annals of epidemiology.

Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study

J. Graham, J. Boscarino, E. Wright, 2021, Rheumatology and Therapy.

Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.

J. Wernicke, A. Wasan, B. Mccarberg, 2009, Current drug safety.

Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies

P. Mantyh, T. Yaksh, Y. D'arcy, 2021, Postgraduate medicine.

Regional Anesthesia and Local Anesthetic-Induced Systemic Toxicity: Seizure Frequency and Accompanying Cardiovascular Changes

D. Schroeder, K. Offord, K P Offord, 1995, Anesthesia and analgesia.

Less common etiologies of exocrine pancreatic insufficiency

Vikesh K. Singh, Mark Haupt, D. Geller, 2017, World journal of gastroenterology.

Poster 6: Duloxetine 60 to 120 mg Once Daily Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain

Jacques P. Brown, Shuyu Zhang, H. Liu-Seifert, 2009 .

Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.

K. Boye, J. Holcombe, R. Swindle, 2010, Journal of diabetes and its complications.

Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials

A. Crucitti, Fujun Wang, B. Utterback, 2010, Expert opinion on drug safety.

Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

D. Fishbain, C. Mallinckrodt, A. Meyers, 2008, Journal of pain and symptom management.

Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis

R. Dworkin, D. Turk, J. Cappelleri, 2023, The Clinical journal of pain.

Factors influencing the implementation and uptake of a discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease: a qualitative focus group study

B. Rowe, S. Field, M. Ospina, 2020, Implementation Science Communications.

Poster 189: Duloxetine as an Effective Treatment for Improving Painful Physical Symptoms and Functioning Associated With Generalized Anxiety Disorder

J. Erickson, C. Allgulander, S. Ball, 2007 .

Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States

R. Burge, Jerry Hall, W. Ye, 2023, Journal of medical economics.

Medication use and comorbidities in an increasingly younger osteoarthritis population: an 18-year retrospective open-cohort study

J. Graham, J. Boscarino, E. Wright, 2023, BMJ Open.

Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

D. Fishbain, C. Mallinckrodt, A. Meyers, 2008, Journal of pain and symptom management.

Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials

A. Crucitti, Fujun Wang, B. Utterback, 2010, Expert opinion on drug safety.